Breo copay assistance program full#

MAT is not its own patient assistance program but rather a search engine for many of the patient assistance resources that the biopharmaceutical industry offers. Is a search engine designed to help patients, caregivers and health care providers learn more about the resources available through the various biopharmaceutical industry programs. For a list of participating pharmacies, medications, and other important information about the program, visit Medicine Assistance Tool (MAT) Through this program, many AstraZeneca products can be accessed at a discounted price, providing savings that are realized immediately at the pharmacy.

Breo copay assistance program full#

This program serves as another option for patients who pay full price at the pharmacy, including those who don’t have insurance, or who are in the deductible phase of a high-deductible commercial insurance plan. For more information, call 1-888-ASK-HRSA or visit Inside Rx SMĮxpress Scripts has introduced a prescription drug discount program called InsideRx and AstraZeneca is one of several pharmaceutical companies participating. HRSA offers information about community health centers that may offer prescription assistance to low-income patients. For more information, visit Health Resources and Services Administration (HRSA) It offers confidential assistance online for seniors and caregivers by searching more than 1,100 federal, state, and private prescription drug programs and determining those for which the senior may be eligible. The National Council on Aging (NCOA) sponsors this website. For more information, visit BenefitsCheckUp ®

The ACU has developed tools and links for implementing comprehensive pharmaceutical care for low-income patients. The ACU is a nonprofit organization that works to help clinicians better serve the needs of low-income patients. To contact your local area agency on aging, call 1-80 or visit Association of Clinicians for the Underserved (ACU) Local area agencies on aging may be able to help patients age 65 years and older who cannot afford their medicines.